|
Volume
8 Number 8
August 2020
|
|
Home
>
Disciplines
>
Publications
>
Prostate
Cancer Reviews >
Volume
8, Year 2020 >
Number 8, August
|
|
|
Contents
|
▼
|
|
Diagnosis,
presentation
|
|
Epidemiology,
risk factors, prevention
|
|
Etiology,
pathogenesis, pathology
|
|
Follow-up,
side effects, quality of life
|
|
Integrative
medicine
|
|
Overall
management
|
|
Prognosis,
outcomes
|
|
Treatment
|
|
|
Diagnosis,
presentation
|
▲
|
|
Alshehri
SZ, Alshahrani OS, Almsaoud NA, Al-Ghamdi MA, Alqahtani AM,
Almurayyi MM, Autwdi AS, Al-Ghamdi SA, Zogan MM, Alamri AM.
The
role of multiparametric magnetic resonance imaging and magnetic
resonance-guided biopsy in active surveillance for low-risk
prostate cancer: A systematic review.
Ann
Med Surg (Lond). 2020 Jul 17. 2020;57:171-178. doi:
10.1016/j.amsu.2020.07.015. Review.
|
|
|
|
Arslan
A, Karaarslan E, Güner
AL, Sağlıcan Y, Tuna MB, Kural AR.
Comparing
the
Diagnostic Performance of Multiparametric Prostate MRI Versus
68Ga-PSMA
PET-
CT
in the Evaluation Lymph Node Involvement and Extraprostatic
Extension.
Acad
Radiol.
2020 Aug 4. 2020;S1076-6332(20)30427-X. doi:
10.1016/j.acra.2020.07.011. Retrospective study.
_
|
|
|
|
Baccaglini
W, Glina FA, Pazeto CL, Medina LG, Korkes F, Bernardo WM, Sotelo
R, Glina S, Marra G, Moschini M, Cathelineau X, Sanchez-Salas R.
Accuracy
of MRI-guided Versus Systematic Prostate Biopsy in Patients Under
Active Surveillance: A Systematic Review and Meta-analysis.
Clin
Genitourin Cancer. 2020 Jul 2. 2020;S1558-7673(20)30147-6. doi:
10.1016/j.clgc.2020.06.008. Review/Meta-analysis.
|
|
|
|
Barbosa
FG, Queiroz MA, Ferraro DA, Nunes RF, Dreyer PR, Zaniboni EC,
Costa LB, Bastos DA, Marin JFG, Buchpiguel CA.
Prostate-specific
Membrane Antigen PET: Therapy Response Assessment in Metastatic
Prostate Cancer.
Radiographics.
2020 Aug 7. 2020;40(5):1412-1430. doi: 10.1148/rg.2020200058.
Review.
_
|
|
|
|
Ferdinandus
J, Fendler WP, Hadaschik B, Herrmann K.
Prostate-specific
membrane antigen targeted PET imaging for prostate cancer
recurrence.
Curr
Opin Urol.
2020 Sep;30(5):635-640. doi: 10.1097/MOU.0000000000000793.
Review.
_
|
|
|
|
Satapathy
S, Singh H, Kumar R, Mittal BR.
Diagnostic
accuracy of 68Ga-PSMA
PET/CT for initial detection in patients with suspected prostate
cancer: A systematic review and meta-analysis.
AJR
Am J Roentgenol.
2020 Jul 22. doi: 10.2214/AJR.20.23912. Review/Meta-analysis.
_
|
|
|
Epidemiology,
risk factors, prevention
|
▲
|
|
Friedenreich
CM, Ryder-Burbidge C, McNeil J.
Physical
activity, obesity and sedentary behavior in cancer etiology:
epidemiologic evidence and biologic mechanisms.
Mol
Oncol. 2020 Aug 2. doi: 10.1002/1878-0261.12772. Review.
|
|
|
|
Sargsyan
A, Dubasi HB.
Milk
Consumption and Prostate Cancer: A Systematic Review.
World
J Mens Health.
2020 Jul 27. doi: 10.5534/wjmh.200051. Review.
_
|
|
|
Etiology,
pathogenesis, pathology
|
▲
|
|
Barth
DA, Juracek J, Slaby O, Pichler M, Calin GA.
lncRNA
and Mechanisms of Drug Resistance in Cancers of the Genitourinary
System.
Cancers
(Basel). 2020 Aug 3. 2020;12(8):E2148. doi:
10.3390/cancers12082148. Review.
|
|
|
|
Gupta
M, Shorman M.
Cytomegalovirus.
StatPearls
2020
Aug 10. NCBI Bookshelf NBK459185. Review.
_
|
|
|
Follow-up,
side effects, quality of life
|
▲
|
|
Bargiota
A, Oeconomou A, Zachos I, Samarinas M, L Pisters L, Tzortzis
V.
Adverse
effects of androgen deprivation therapy in patients with prostate
cancer: Focus on muscle and bone health.
J
BUON.
2020 May-Jun;25(3):1286-1294.
Review.
_
|
|
|
|
Corona
G, Filippi S, Bianchi N, Dicuio M, Rastrelli G, Concetti S, Sforza
A, Maggi M.
Cardiovascular
Risks of Androgen Deprivation Therapy for Prostate Cancer.
World
J Mens Health. 2020 Aug 18. doi: 10.5534/wjmh.200109. Review.
|
|
|
|
Cui
H, Wang Y, Li F, He G, Jiang Z, Gang X, Wang G.
Quantifying
observational evidence for risk of dementia following androgen
deprivation therapy for prostate cancer: an updated systematic
review and meta-analysis.
Prostate
Cancer Prostatic Dis. 2020 Aug 19. doi:
10.1038/s41391-020-00267-3.
Review/Meta-analysis.
|
|
|
|
Lee
HH, Park S, Joung JY, Kim SH.
How
Does Androgen Deprivation Therapy Affect Mental Health Including
Cognitive Dysfunction In Patients with Prostate Cancer?
World
J Mens Health. 2020 Jul 21. doi: 10.5534/wjmh.200092. Review.
|
|
|
|
Marcu
DR, Iorga L, Diaconu CC, Spinu AD, Mischianu D, Bratu OG.
Benefits
of erectile function recovery programs after radical prostatectomy
(Review).
Exp
Ther Med. 2020 Jun 24. 2020;20(3):2406-2410. doi:
10.3892/etm.2020.8934. Review.
|
|
|
Integrative
medicine
|
▲
|
|
Abe
SK, Inoue M.
Green
tea and cancer and cardiometabolic diseases: a review of the
current epidemiological evidence.
Eur
J Clin Nutr. 2020 Aug 20. doi: 10.1038/s41430-020-00710-7. Review.
|
|
|
|
Mirahmadi
M, Azimi-Hashemi S, Saburi E, Kamali H, Pishbin M, Hadizadeh
F.
Potential
inhibitory effect of lycopene on prostate cancer.
Biomed
Pharmacother. 2020 Jun 30. 2020;129:110459. doi:
10.1016/j.biopha.2020.110459. Review.
|
|
|
Overall
management
|
▲
|
|
Broderick
JM.
Experts
Develop New Guideline for Advanced Prostate Cancer.
Oncology
(Williston
Park). 2020 Aug 12;34(8):305-306. doi:
10.46883/ONC.2020.3408.0305. Comment.
_
Refers
to: Lowrance W, Breau R, Chou R, Chapin BF, Crispino T, Dreicer R,
Jarrard DF, Kibel AS, Morgan TM, Morgans, Oh WK, Resnick M,
Zietman A, Cookson MS. Advanced Prostate Cancer: AUA/ASTRO/SUO
Guideline.
Am
Urol Assoc.
2020. http://www.auanet.org/guidelines/advanced-prostate-cancer.
Guidelines.
_
|
|
|
|
Lowrance W, Breau R, Chou R, Chapin BF, Crispino T, Dreicer R,
Jarrard DF, Kibel AS, Morgan TM, Morgans, Oh WK, Resnick M,
Zietman A, Cookson MS.
Advanced Prostate Cancer:
AUA/ASTRO/SUO Guideline.
Am
Urol Assoc. 2020.
http://www.auanet.org/guidelines/advanced-prostate-cancer.
Guidelines. _
|
|
|
|
Rohan
P, O'Reilly MK, Nason GJ.
Artificial
Intelligence - Changing the Field of Prostate Cancer?
Ir
Med J.
2020
Mar 13. 2020;113(3):45. Letter to the Editor.
_
|
|
|
|
Schoots
IG, Barentsz JO, Bittencourt LK, Haider MA, Macura KJ, Margolis
DJA, Moore CM, Oto A, Panebianco V, Siddiqui MM, Tempany C,
Turkbey B, Villeirs GM, Weinreb JC, Padhani AR.
PI-RADS
Committee Position on MRI Without Contrast Medium in Biopsy Naive
Men with Suspected Prostate Cancer: A Narrative Review.
AJR
Am J Roentgenol.
2020 Aug 19. doi: 10.2214/AJR.20.24268.
Review.
_
|
|
|
|
Shore
ND, Drake CG, Lin DW, Ryan CJ, Stratton KL, Dunshee C, Karsh LI,
Kaul S, Kernen K, Pieczonka C, Sieber P, Stewart C, Williams M,
Concepcion RS.
Optimizing
the management of castration-resistant prostate cancer patients: A
practical guide for clinicians.
Prostate.
2020 Aug 11. doi: 10.1002/pros.24053. Guidelines.
|
|
|
|
van
Leenders GJLH, van der Kwast TH, Iczkowski KA.
The
2019 International Society of Urological Pathology Consensus
Conference on Prostate Cancer Grading.
Eur
Urol.
2020 Aug 23. 2020;S0302-2838(20)30618-7. doi:
10.1016/j.eururo.2020.08.004. Meetings.
_
|
|
|
Prognosis,
outcomes
|
▲
|
|
Saxby
H, Mikropoulos C, Boussios S.
An
Update on the Prognostic and Predictive Serum Biomarkers in
Metastatic Prostate Cancer.
Diagnostics
(Basel). 2020 Jul 31. 2020;10(8):E549. doi:
10.3390/diagnostics10080549. Review.
|
|
|
|
Sobhani
N, Sirico M, Generali D, Zanconati F, Scaggiante B.
Circulating
cell-free nucleic acids as prognostic and therapy predictive tools
for metastatic castrate-resistant prostate cancer.
World
J Clin Oncol. 2020 Jul 24. 2020;11(7):450-463. doi:
10.5306/wjco.v11.i7.450. Review.
|
|
|
|
Tian
S, Lei Z, Gong Z, Sun Z, Xu D, Piao M.
Clinical
implication of prognostic and predictive biomarkers for
castration-resistant prostate cancer: a systematic review.
Cancer
Cell Int. 2020 Aug 26. 2020;20:409. doi:
10.1186/s12935-020-01508-0. Review.
|
|
|
Treatment
|
▲
|
|
Almeida
G, Tavares JMRS.
Deep Learning in Radiation Oncology
Treatment Planning for Prostate Cancer: A Systematic Review.
J
Med Syst. 2020 Aug 30. 2020;44(10):179. doi:
10.1007/s10916-020-01641-3. Review.
|
|
|
|
Antonarakis
ES, Gomella LG, Petrylak DP.
When
and How to Use PARP Inhibitors in Prostate Cancer: A Systematic
Review of the Literature with an Update on On-Going Trials.
Eur
Urol Oncol. 2020 Aug 17. 2020;S2588-9311(20)30096-1. doi:
10.1016/j.euo.2020.07.005. Review.
|
|
|
|
Crawford
ED, Stanton W, Mandair D.
Darolutamide:
An Evidenced-Based Review of Its Efficacy and Safety in the
Treatment of Prostate Cancer.
Cancer
Manag Res. 2020 Jul 13. 2020;12:5667-5676. doi:
10.2147/CMAR.S227583. Review.
|
|
|
|
Delgadillo
R, Ford JC, Abramowitz MC, Dal Pra A, Pollack A, Stoyanova R.
The
role of radiomics in prostate cancer radiotherapy.
Strahlenther
Onkol. 2020 Aug 21. doi: 10.1007/s00066-020-01679-9. Review.
|
|
|
|
Enikeev
D, Morozov A, Taratkin M, Barret E, Kozlov V, Singla N, Rivas JG,
Podoinitsin A, Margulis V, Glybochko P.
Active
Surveillance for Intermediate-Risk Prostate Cancer: Systematic
Review and Meta-analysis of Current Protocols and Outcomes.
Clin
Genitourin Cancer. 2020 May 22. 2020;S1558-7673(20)30116-6. doi:
10.1016/j.clgc.2020.05.008.
Review/Meta-analysis.
|
|
|
|
Kiełbik
A, Szlasa W, Saczko J, Kulbacka J.
Electroporation-Based
Treatments in Urology.
Cancers
(Basel). 2020 Aug 7. 2020;12(8):2208. doi:
10.3390/cancers12082208. Review.
|
|
|
|
Kim
TJ, Koo KC.
Current
Status and Future Perspectives of Checkpoint Inhibitor
Immunotherapy for Prostate Cancer: A Comprehensive Review.
Int
J Mol Sci. 2020 Jul 31. 2020;21(15):5484. doi:
10.3390/ijms21155484. Review.
|
|
|
|
Kucharczyk
MJ, So J, Gravis G, Sweeney C, Saad F, Niazi T.
A
combined biological and clinical rationale for evaluating
metastasis directed therapy in the management of oligometastatic
prostate cancer.
Radiother
Oncol. 2020 Aug 25. 2020;S0167-8140(20)30729-5. doi:
10.1016/j.radonc.2020.08.011. Review.
|
|
|
|
Moris
L, Cumberbatch MG, Van den Broeck T, Gandaglia G, Fossati N, Kelly
B, Pal R, Briers E, Cornford P, De Santis M, Fanti S, Gillessen S,
Grummet JP, Henry AM, Lam TBL, Lardas M, Liew M, Mason MD, Omar
MI, Rouvière O, Schoots IG, Tilki D, van den Bergh RCN, van
Der Kwast TH, van Der Poel HG, Willemse PM, Yuan CY, Konety B,
Dorff T, Jain S, Mottet N, Wiegel T.
Benefits
and Risks of Primary Treatments for High-risk Localized and
Locally Advanced Prostate Cancer: An International
Multidisciplinary Systematic Review.
Eur
Urol.
2020 Mar 4. 2020;77(5):614-627. doi: 10.1016/j.eururo.2020.01.033.
Review.
_
|
|
|
|
Morozov
A, Taratkin M, Barret E, Singla N, Bezrukov E, Chinenov D, Enikeev
M, Gomez Rivas J, Shpikina A, Enikeev D.
A
systematic review of irreversible electroporation in localised
prostate cancer treatment.
Andrologia.
2020 Aug 12. 2020;e13789. doi: 10.1111/and.13789. PMID: 32786087.
Review.
|
|
|
|
Rosenberg
JE, Jung JH, Edgerton Z, Lee H, Lee S, Bakker CJ, Dahm P.
Retzius-sparing
versus standard robotic-assisted laparoscopic prostatectomy for
the treatment of clinically localized prostate cancer.
Cochrane
Database Syst Rev. 2020 Aug 18. 2020;8(8):CD013641. doi:
10.1002/14651858.CD013641.pub2. Review.
|
|
|
|
Sachdev
S, Carroll P, Sandler H, Nguyen PL, Wafford E, Auffenberg G,
Schaeffer E, Roach M 3rd, Evans CP, Hussain M.
Assessment
of Postprostatectomy Radiotherapy as Adjuvant or Salvage Therapy
in Patients With Prostate Cancer: A Systematic Review.
JAMA
Oncol.
2020 Aug 27. doi: 10.1001/jamaoncol.2020.2832.
Review.
_
|
|
|
|
Sosnowski
R, Kamecki H, Daneshmand S, Rudzinski JK, Bjurlin MA, Giganti F,
Roobol MJ, Klotz L.
Active
surveillance for low-risk prostate cancer – in pursuit of a
standardized protocol.
Cent
European J Urol. 2020 Jun 25. 2020;73(2):123-126. doi:
10.5173/ceju.2020.0167. Review.
|
|
|
|
Sun
M, Niaz MO, Nelson A, Skafida M, Niaz MJ.
Review
of 177Lu-PSMA-617 in Patients With Metastatic Castration-Resistant
Prostate Cancer.
Cureus.
2020 Jun 30. 2020;12(6):e8921. doi: 10.7759/cureus.8921. Review.
|
|
|
bottom
|
▲
|
|
|
***********************
|
|
